| Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics S Marrache, S Dhar Proceedings of the National Academy of Sciences 109 (40), 16288-16293, 2012 | 493 | 2012 |
| The Prodrug Platin‐A: Simultaneous Release of Cisplatin and Aspirin RK Pathak, S Marrache, JH Choi, TB Berding, S Dhar Angewandte Chemie International Edition 53 (7), 1963-1967, 2014 | 259 | 2014 |
| Detouring of cisplatin to access mitochondrial genome for overcoming resistance S Marrache, RK Pathak, S Dhar Proceedings of the National Academy of Sciences 111 (29), 10444-10449, 2014 | 234 | 2014 |
| Biodegradable synthetic high-density lipoprotein nanoparticles for atherosclerosis S Marrache, S Dhar Proceedings of the National Academy of Sciences 110 (23), 9445-9450, 2013 | 143 | 2013 |
| Mito-DCA: a mitochondria targeted molecular scaffold for efficacious delivery of metabolic modulator dichloroacetate RK Pathak, S Marrache, DA Harn, S Dhar ACS chemical biology 9 (5), 1178-1187, 2014 | 133 | 2014 |
| Ex Vivo Programming of Dendritic Cells by Mitochondria-Targeted Nanoparticles to Produce Interferon-Gamma for Cancer Immunotherapy S Marrache, S Tundup, DA Harn, S Dhar ACS nano 7 (8), 7392-7402, 2013 | 131 | 2013 |
| The energy blocker inside the power house: Mitochondria targeted delivery of 3-bromopyruvate S Marrache, S Dhar Chemical science 6 (3), 1832-1845, 2015 | 97 | 2015 |
| Immune stimulating photoactive hybrid nanoparticles for metastatic breast cancer S Marrache, JH Choi, S Tundup, D Zaver, DA Harn, S Dhar Integrative biology 5 (1), 215-223, 2013 | 54 | 2013 |
| Evaluation of nanoparticle delivered cisplatin in beagles B Feldhaeusser, SR Platt, S Marrache, N Kolishetti, RK Pathak, ... Nanoscale 7 (33), 13822-13830, 2015 | 44 | 2015 |
| Nanocarriers for tracking and treating diseases S Marrache, R Kumar Pathak, K L Darley, J H Choi, D Zaver, N Kolishetti, ... Current medicinal chemistry 20 (28), 3500-3514, 2013 | 43 | 2013 |
| Defective hCNT1 transport contributes to gemcitabine chemoresistance in ovarian cancer subtypes: overcoming transport defects using a nanoparticle approach SW Hung, S Marrache, S Cummins, YD Bhutia, H Mody, SB Hooks, ... Cancer letters 359 (2), 233-240, 2015 | 35 | 2015 |
| Pharmacological reversal of histone methylation presensitizes pancreatic cancer cells to nucleoside drugs: in vitro optimization and novel nanoparticle delivery studies SW Hung, H Mody, S Marrache, YD Bhutia, F Davis, JH Cho, J Zastre, ... PloS one 8 (8), e71196, 2013 | 28 | 2013 |
| Apoptosis-targeting nanoparticles S Dhar, S Marrache US Patent 9,901,616, 2018 | 17 | 2018 |
| Immune-stimulating photoactive hybrid nanoparticles S Dhar, J Choi, S Marrache US Patent 9,517,277, 2016 | 16 | 2016 |
| Formulation and optimization of mitochondria-targeted polymeric nanoparticles S Marrache, RK Pathak, S Dhar Mitochondrial Medicine: Volume II, Manipulating Mitochondrial Function, 103-112, 2015 | 15 | 2015 |
| Ex vivo generation of functional immune cells by mitochondria-targeted photosensitization of cancer cells S Marrache, S Tundup, DA Harn, S Dhar Mitochondrial Medicine: Volume II, Manipulating Mitochondrial Function, 113-122, 2015 | 9 | 2015 |
| Nanoparticles for mitochondrial trafficking of agents S Dhar, SM Marrache US Patent 10,416,167, 2019 | 8 | 2019 |
| Mitochondrial delivery of 3-bromopyruvate S Dhar, S Marrache US Patent 10,398,663, 2019 | 8 | 2019 |
| Core hydrophobicity tuning of a self-assembled particle results in efficient lipid reduction and favorable organ distribution B Banik, R Wen, S Marrache, A Kumar, N Kolishetti, EW Howerth, S Dhar Nanoscale 10 (1), 366-377, 2018 | 8 | 2018 |
| Therapeutic nanoparticles for accumulation in the brain S Dhar, EW Baker, S Marrache, FD West US Patent App. 15/501,022, 2017 | 6 | 2017 |
